메뉴 건너뛰기




Volumn 10, Issue 6, 2005, Pages 438-440

A new therapeutic approach in patients with advanced sarcoma

Author keywords

Antiangiogenic; Oral; Proapoptotic; Sarcoma

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROFECOXIB; TROFOSFAMIDE;

EID: 29244477812     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-005-0514-9     Document Type: Article
Times cited : (11)

References (6)
  • 1
    • 4444286921 scopus 로고    scopus 로고
    • Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma
    • SS Yoon NH Segal AB Olshen 2004 Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma Ann Oncol 15 1261 1266
    • (2004) Ann Oncol , vol.15 , pp. 1261-1266
    • Yoon, S.S.1    Segal, N.H.2    Olshen, A.B.3
  • 2
    • 0031671246 scopus 로고    scopus 로고
    • Differentiation and reversal of malignant changes in colon cancer through PPARγ
    • P Sarraf E Mueller D Jones 1998 Differentiation and reversal of malignant changes in colon cancer through PPARγ Nat Med 4 1046 1052
    • (1998) Nat Med , vol.4 , pp. 1046-1052
    • Sarraf, P.1    Mueller, E.2    Jones, D.3
  • 3
    • 0035522744 scopus 로고    scopus 로고
    • Approach to angiogenesis inhibition based on cyclooxygenase-2
    • Suppl 3
    • J Masferrer 2001 Approach to angiogenesis inhibition based on cyclooxygenase-2 Cancer J 7 Suppl 3 S144 S150
    • (2001) Cancer J , vol.7
    • Masferrer, J.1
  • 4
    • 0242526860 scopus 로고    scopus 로고
    • Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors
    • T Vogt C Hafner K Bross 2003 Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors Cancer 15 2251 2256
    • (2003) Cancer , vol.15 , pp. 2251-2256
    • Vogt, T.1    Hafner, C.2    Bross, K.3
  • 5
    • 7644238341 scopus 로고    scopus 로고
    • Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft-tissue sarcoma
    • A Reichle K Bross T Vogt 2004 Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft-tissue sarcoma Cancer 101 2247 2256
    • (2004) Cancer , vol.101 , pp. 2247-2256
    • Reichle, A.1    Bross, K.2    Vogt, T.3
  • 6
    • 0032764436 scopus 로고    scopus 로고
    • Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma
    • C Kollmannsberger W Brugger JT Hartmann 1999 Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma Anticancer Drugs 10 453 456
    • (1999) Anticancer Drugs , vol.10 , pp. 453-456
    • Kollmannsberger, C.1    Brugger, W.2    Hartmann, J.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.